Abstract:Abstracttrans-Diaminedicholoroplatinum(II) complexes with one planar and one non-planar heterocyclic amine ligand were designed as new potential antitumor drugs. The X-ray crystallographic structures of trans-[PtCl2(4-picoline)(piperidine)] and trans-[PtCl2(4-picoline)(piperazine)]·HCl revealed that the piperidine and piperazine ligands bind to the platinum through the equatorial position and that the ligands adopt the chair conformation. The nonplatinated amine of the piperazine can form hydrogen bonds with atoms that are approximately 7.5 Å away from the Pt binding site. DNA is considered a major pharmacological target of platinum compounds. Hence, to expand the database correlating structural features of platinum compounds and DNA distortions induced by these compounds, which may facilitate identification of more effective anticancer platinum drugs, we describe the DNA binding mode in a cell-free medium of trans-[PtCl2(4-picoline)(piperidine)] and trans-[PtCl2(4-picoline)(piperazine)]·HCl. Interestingly, the overall impact of the replacement of the second ammine group in transplatin by the heterocyclic ligands appears to change the character of the global conformational changes induced in DNA towards that induced by cisplatin. The clinical ineffectiveness of the parent transplatin has been proposed to be also associated with its reduced capability to form bifunctional adducts in double-helical DNA. The results of the present work support the view that replacement of both ammine groups of transplatin by heterocyclic ligands enhances cytotoxicity probably due to the marked enhancement of the stability of intrastrand cross-links in double-helical DNA.

Structural changes of linear DNA molecules induced by cisplatin.

The interactions of cisplatin and DNA studied by atomic force microscopy.

Structural study on the interactions of oxaliplatin and linear DNA.

Molecular Dynamics Studies of Changes in the DNA- Structure as Result of Interactions with Cisplatin

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

Cisplatin treatment leads to changes in nuclear protein and microRNA expression

Study on the Interactions Between Anti-Cancer Drug Oxaliplatin and DNA

Study on the interactions between anti-cancer drug oxaliplatin and DNA by atomic force microscopy

Study on the interactions between cisplatin and cadherin

Study on the Interactions Between Cisplatin and Cadherin by Fluorescence Spectrometry and Atomic Force Microscopy.

Atomic force microscopy studies on DNA structural changes induced by vincristine sulfate and aspirin.

Nuclear proteome analysis of cisplatin-treated HeLa cells

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Sequence-Dependent Bending of DNA Induced by Cisplatin: NMR Structures of an A⋅T-Rich 14-Mer Duplex

Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression

Binding Stability of a Cross-Linked Drug: Calculation of an Anticancer Drug Cisplatin-Dna Complex

Structure and Mechanism of Human DNA Polymerase Η

Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II)

Proteomic Analysis of Cisplatin- and Oxaliplatin-Induced Phosphorylation in Proteins Bound to Pt-DNA Adducts.

The Role of Bridging Ligands in Determining DNA-binding Ability and Cross-Linking Patterns of Dinuclear Platinum(ii) Antitumour Complexes.

Proteomic Strategy for Identification of Proteins Responding to Cisplatin-Damaged DNA.